- Home
- SNAX vs XYLO Comparison
SNAX vs XYLO Comparison
Compare SNAX & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAX
- XYLO
- Stock Information
- Founded
- SNAX 2017
- XYLO 1999
- Country
- SNAX United States
- XYLO Israel
- Employees
- SNAX N/A
- XYLO N/A
- Industry
- SNAX Packaged Foods
- XYLO
- Sector
- SNAX Consumer Staples
- XYLO
- Exchange
- SNAX Nasdaq
- XYLO NYSE
- Market Cap
- SNAX 2.7M
- XYLO 3.1M
- IPO Year
- SNAX N/A
- XYLO N/A
- Fundamental
- Price
- SNAX $0.75
- XYLO $4.73
- Analyst Decision
- SNAX
- XYLO
- Analyst Count
- SNAX 0
- XYLO 0
- Target Price
- SNAX N/A
- XYLO N/A
- AVG Volume (30 Days)
- SNAX 128.6K
- XYLO 16.2K
- Earning Date
- SNAX 11-13-2024
- XYLO 09-20-2024
- Dividend Yield
- SNAX N/A
- XYLO N/A
- EPS Growth
- SNAX N/A
- XYLO N/A
- EPS
- SNAX N/A
- XYLO N/A
- Revenue
- SNAX $19,364,939.00
- XYLO $57,642,000.00
- Revenue This Year
- SNAX $30.31
- XYLO $16.76
- Revenue Next Year
- SNAX N/A
- XYLO $5.71
- P/E Ratio
- SNAX N/A
- XYLO N/A
- Revenue Growth
- SNAX N/A
- XYLO N/A
- 52 Week Low
- SNAX $0.55
- XYLO $2.70
- 52 Week High
- SNAX $2.33
- XYLO $9.07
- Technical
- Relative Strength Index (RSI)
- SNAX 50.42
- XYLO 61.62
- Support Level
- SNAX $0.70
- XYLO $4.19
- Resistance Level
- SNAX $0.77
- XYLO $4.88
- Average True Range (ATR)
- SNAX 0.08
- XYLO 0.49
- MACD
- SNAX 0.01
- XYLO 0.04
- Stochastic Oscillator
- SNAX 45.54
- XYLO 75.54
About SNAX Stryve Foods Inc.
Stryve Foods Inc is a healthy snacking company that manufactures, markets, and sells differentiated healthy snacking products. The company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.